Advertisement

Introduction

  • Saskia K. NagelEmail author
Chapter
Part of the Advances in Neuroethics book series (AIN)

Abstract

How to best prepare children for life? How to develop settings for childcare and adolescent maturation that support the developing individual within a changing societal context? How to understand and evaluate expectations concerning behaviour and performance in childhood and youth? How to understand what is fruitful for increasing a child’s present and future well-being? How to decide for, and with, children?

References

  1. Banjo OC, Nadler R, Reiner PB (2010) Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount. PLoS One 5(12):e14322CrossRefPubMedPubMedCentralGoogle Scholar
  2. Bell S, Partridge B, Lucke J, Hall W (2013) Australian university students’ attitudes towards the acceptability and regulation of pharmaceuticals to improve academic performance. Neuroethics 6(1):197–205CrossRefGoogle Scholar
  3. Centers for Disease Control and Prevention (CDC) (2010) Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children—United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep 59:1439–1443Google Scholar
  4. Conrad P (2007) The Medicalization of Society: on the transformation of human conditions into treatable disorders. Johns Hopkins Press, BaltimoreGoogle Scholar
  5. Flanigan J (2013) Adderall for all? A defense of pediatric neuroenhancement. HEC Forum 25:325–344CrossRefGoogle Scholar
  6. Forlini C, Schildmann J, Roser P et al (2015) Knowledge, experiences and views of German University students toward neuroenhancement: an empirical-ethical analysis. Neuroethics 8:83.  https://doi.org/10.1007/s12152-014-9218-zCrossRefGoogle Scholar
  7. Gaucher N et al (2013) Cognitive enhancement in children and adolescents: is it in their best interests? Acta Paediatr 102(12):1118–1124.  https://doi.org/10.1111/apa.12409CrossRefPubMedGoogle Scholar
  8. Ghaeus A (2017) Parental genetic shaping and parental environmental shaping. Philos Q 67(267):20–31Google Scholar
  9. Gillies V, Edwards R, Horsley N (2016) Brave new brains: sociology, family and the politics of knowledge. Sociol Rev 64(2):219–237CrossRefGoogle Scholar
  10. Graf WD, Singh I (2015) Can guidelines help reduce the medicalization of early childhood? J Pediatr 166:1344–1346CrossRefPubMedGoogle Scholar
  11. Graf WD, Nagel SK, Epstein LG, Miller G, Nass R, Larriviere D (2013) Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications. Neurology 80(13):1251–1260CrossRefPubMedGoogle Scholar
  12. Graf WD, Miller G, Nagel SK (2014) Addressing the problem of ADHD medication as neuroenhancements. Exp Rev Neurotherap 14(5):569–581.  https://doi.org/10.1586/14737175.2014.908707CrossRefGoogle Scholar
  13. Hays S (1996) The cultural contradictions of motherhood. Yale University Press, New HavenGoogle Scholar
  14. Hens K, Cutas D, Horstkötter D (2017) Parental responsibility in the context of neuroscience and genetics. Parental responsibility in the context of neuroscience and genetics, vol 69. Springer.  https://doi.org/10.1007/978-3-319-42834-5Google Scholar
  15. Hinshaw SP, Scheffler RM (2014) The ADHD explosion: myths, medication, money, and today’s push for performance. ISBN: 0199790558Google Scholar
  16. Kipke R (2011) Besser werden–Eine ethische Untersuchung zu Selbstformung und Neuro-Enhancement. Mentis, PaderbornGoogle Scholar
  17. Kroutil LA, Van Brunt DL, Herman-Stahl MA, Heller DC, Bray RM, Penne MA (2006) Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend 84:135–143CrossRefPubMedGoogle Scholar
  18. Mauron A, Hurst S (2010) From Ritalin to malignant teaching—the fuzzy borders of neuroenhancement. Ajob Neurosci 1:31–33CrossRefGoogle Scholar
  19. Mayes R, Bagwell C, Erkulwater J (2008) ADHD and the rise in stimulant use among children. Harv Rev Psychiatry 16(3):151–166CrossRefPubMedGoogle Scholar
  20. Mazanov J, Dunn M, Connor J, Fielding M-L (2014) Substance use to enhance academic performance among Australian university students. Perform Enhanc Health 2(3):110–118CrossRefGoogle Scholar
  21. McCabe SE, West BT, Cranford JA et al (2011) Medical misuse of controlled medications among adolescents. Arch Pediatr Adolesc Med 165:729–735CrossRefPubMedPubMedCentralGoogle Scholar
  22. Nadesan MH (2002) Engineering the entrepreneurial infant: brain science, infant development toys, and governmentality. Cult Stud 16(3):401–432CrossRefGoogle Scholar
  23. Nagel SK (2010) Too much of a good thing? Enhancement and the burden of self-determination. Neuroethics 3(2):109–119CrossRefGoogle Scholar
  24. Nagel SK (forthcoming) Pharmakologisches Enhancement von Kindern und Jugendlichen – Praktische, soziale und ethische Fragen. In: Schweiger G, Drerup J (eds) Handbuch Philosophie der Kindheit. J.B. Metzler Verlag, StuttgartGoogle Scholar
  25. O’Connor C, Nagel SK (2017) Neuro-enhancement practices across the lifecourse: exploring the roles of relationality and individualism. Front Sociol.  https://doi.org/10.3389/fsoc.2017.00001
  26. Parens E (ed) (1998) Enhancing human traits: ethical and social implications. Georgetown University Press, Washington, DC. ISBN: 0878407804Google Scholar
  27. Parens E (ed) (2008) Surgically shaping children. Johns Hopkins University Press, Baltimore. ISBN: 780801890901Google Scholar
  28. Rasmussen N (2008) America’s first amphetamine epidemic 1929-1971: a quantitative and qualitative retrospective with implications for the present. Am J Public Health 98(6):974–985CrossRefPubMedPubMedCentralGoogle Scholar
  29. Sattler S, Singh I (2016) Cognitive enhancement in healthy children will not close the achievement gap in education. http://www.tandfonline.com/doi/full/10.1080/15265161.2016.1170240CrossRefGoogle Scholar
  30. Savulescu J (2011) Human liberation: removing biological and psychological barriers to freedom. Monash Bioeth Rev 29(1):04.1–04.18Google Scholar
  31. Schelle KJ, Faulmuller N, Caviola L, Hewstone M (2014) Attitudes toward pharmacological cognitive enhancement—a review. Front Syst Neurosci.  https://doi.org/10.3389/fnsys.2014.00053
  32. Singh I (2005) Will the “real boy” please behave: dosing dilemmas for parents of boys with ADHD. Am J Bioethics 5:34–47CrossRefGoogle Scholar
  33. Singh I, Kelleher KJ (2010) Neuroenhancement in young people: proposal for research, policy and clinical management. Am J Bioeth Neurosci 1(1):3–16Google Scholar
  34. Wall G (2010) Mothers’ experiences with intensive parenting and brain development discourse. Women’s Stud Int Forum 33(3):253–263CrossRefGoogle Scholar
  35. White BP, Becker-Blease KA, Grace-Bishop K (2006) Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample. J Am Coll Health 54(5):261–268CrossRefPubMedGoogle Scholar
  36. Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F (2000) Trends in the prescribing of psychotropic medications to preschoolers. JAMA 283:1025–1030CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Human Technology Center, RWTH Aachen UniversityAachenGermany
  2. 2.Department of PhilosophyUniversity of TwenteEnschedeThe Netherlands

Personalised recommendations